|
0
|
|
Alcohol reshapes liver zonal plasticity and immune-metabolic reprogramming in metabolic-syndrome associated hepatocellular carcinoma.
(nature.com)
|
Tian T
…
Pi L
Nature Communications
2026-08-22
|
#hepatocellular carcinoma
#metabolism
#immunosuppression
#steatohepatitis
#immunotherapy
|
|
0
|
|
The promise of monoclonal antibody interventions in malaria: A narrative review.
(linkinghub.elsevier.com)
|
Rashid MA
…
Berens-Riha N
Clinical Microbiology and Infection
2026-08-22
|
#malaria
#antibody
#immunotherapy
#immunity
#parasite
|
|
0
|
|
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.
(linkinghub.elsevier.com)
|
Sun HC
…
Fan J
The Lancet
2026-08-22
|
#hepatocellular carcinoma
#clinical trial
#immunotherapy
#surgery
#oncology
|
|
0
|
|
Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial.
(nature.com)
|
Valero V
…
Meric-Bernstam F
Nature Communications
2026-08-22
|
#breast cancer
#her2
#neoadjuvant
#biomarker
#immunotherapy
|
|
0
|
|
XPO1-mediated TRIM21 nuclear export reprograms TREM2+ macrophage polarization by targeting IRF3 to augment anti-PD-1 efficacy in small cell lung cancer.
(nature.com)
|
Du Q
…
Huang D
Nature Communications
2026-08-22
|
#immunotherapy
#macrophage
#lung cancer
#immunosuppression
#checkpoint-inhibitors
|
|
0
|
|
CX3CR1(+) CD8(+) cytotoxic T cells drive tumor killing in esophageal squamous cell carcinoma during neoadjuvant therapy.
(nature.com)
|
Zhao Y
…
Liu Z
Nature Communications
2026-08-22
|
#immunotherapy
#esophageal cancer
#cytotoxic-t-cells
#tumor microenvironment
#single-cell sequencing
|
|
0
|
|
Constitutive natural killer cell features associated with post-treatment control of SIV infection in the pVISCONTI study.
(nature.com)
|
Chapel A
…
Saez-Cirion A
Nature Communications
2026-08-22
|
#immunity
#hiv
#remission
#immunotherapy
|